Recently by Randolph V. Clower
Healthcare
Getting Personal With The Future Of Medicine
Editor: What exactly is Personalized Medicine (PM)? Clower: PM is the use of drugs or other medical devices and technologies, specifically tailored to an individual’s genetic makeup, to hasten the diagnosis and treatment of disease. Today, technologies surrounding PM are rapidly advancing...
Read MoreHealthcare | Life Sciences
A Landmark Case Comes Down
Editor: Please describe your background as a life science patent attorney at Phillips Lytle. Clower: I hold a PhD in molecular biology from the University at Buffalo School of Medicine and Biomedical Sciences, where my research focused on elucidating the bimolecular mechanisms of mammalian DNA...
Read MoreBiotechnology | Life Sciences
Impending Myriad Decision Portends Promethean Consequences For Biotech Industry
Of technologies most likely to enjoy patent protection, a large percentage disproportionately emanate from a limited number of industries. Biotechnology is one such “patent-intensive” industry. Taken together, these industries constitute a foundation for supporting the development of...
Read More